Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Jeffrey J. Raizer
NT113, a Pan-Erbb Inhibitor With High Brain Penetrance, Inhibits the Growth of Glioblastoma Xenografts With EGFR Amplification
Molecular Cancer Therapeutics
Cancer Research
Oncology
Phase II Trials of Erlotinib or Gefitinib in Patients With Recurrent Meningioma
Journal of Neuro-Oncology
Cancer Research
Oncology
Neurology
Related publications
High Level EGFR Amplification in a Newly Established Glioblastoma Cell Line 170-Mg-Ba
Neoplasma
Cancer Research
Mesenchymal Stromal Cells Loaded With Paclitaxel Induce Cytotoxic Damage in Glioblastoma Brain Xenografts
Stem Cell Research and Therapy
Genetics
Cell Biology
Molecular Biology
Biochemistry
Medicine
Molecular Medicine
Mutant-Selective Irreversible EGFR Inhibitor, Naquotinib, Inhibits Tumor Growth in NSCLC Models With EGFR Activating Mutations, T790M Mutation and AXL Overexpression
Molecular Cancer Therapeutics
Cancer Research
Oncology
The Influence of the Combined Treatment With Vadimezan (ASA404) and Taxol on the Growth of U251 Glioblastoma Xenografts
BMC Cancer
Cancer Research
Oncology
Genetics
Epidermal Growth Factor Receptor (EGFR) Is Overexpressed in Anaplastic Thyroid Cancer, and the EGFR Inhibitor Gefitinib Inhibits the Growth of Anaplastic Thyroid Cancer
Clinical Cancer Research
Cancer Research
Oncology
A Small-Molecule Oligosaccharyltransferase Inhibitor With Pan-Flaviviral Activity
Cell Reports
Biochemistry
Genetics
Molecular Biology
A Brain-Penetrant MET Inhibitor Achieves Responses in Glioblastoma
Cancer Discovery
Oncology
PCC0208027, a Novel Tyrosine Kinase Inhibitor, Inhibits Tumor Growth of NSCLC by Targeting EGFR and HER2 Aberrations
Scientific Reports
Multidisciplinary
EGFR Cooperates With EGFRvIII to Recruit Macrophages in Glioblastoma
Cancer Research
Cancer Research
Oncology
